Angiotensin-converting enzyme inhibitor therapy in chronic hemodialysis patients: Any evidence of erythropoietin resistance?

American Journal of Kidney Diseases

Volumn 28, Issue 4, 1996, Pages 535-540

  Cruz, Dinna N ^a   Perazella, Mark A ^a   Abu Alfa, Ali K ^a   Mahnensmith, Rex L ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

anemia; Angiotensin converting enzyme inhibitor; end stage renal disease; erythropoietin

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROPOIETIN RECEPTOR;

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; BONE MARROW SUPPRESSION; CONGESTIVE HEART FAILURE; ENZYME INHIBITION; ERYTHROPOIESIS; FEMALE; HEMATOCRIT; HEMODIALYSIS; HUMAN; HYPERTENSION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PLASMA VOLUME;

EID: 0029819150     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(96)90464-3     Document Type: Article

References (16)

1. Hirakata H, Onayama K, Iseki K, Kumagai H, Fujimi S, Omae T: Worsening of anemia induced by long-term use of captopril in hemodialysis patients. Am J Nephrol 4:355-360, 1984
2. Hirakata H, Onayama K, Hori K, Fujishima M: Participation of the renin-angiotensin system in the captopril-induced worsening of anemia in chronic hemodialysis patients. Clin Nephrol 26:27-32, 1986
3. Onayama K, Sanai T, Motomura K, Fujishima M: Worsening of anemia by angiotensin converting enzyme inhibitors and its prevention by antiestrogenic steroid in chronic hemodialysis patients. J Cardiovasc Pharmacol 13:S27-S30, 1989 (suppl 3)
4. Vlahakos DV, Canzanello VJ, Madaio MP, Madias NE: Enalapril-associated anemia in renal transplant recipients treated for hypertension. Am J Kidney Dis 17:199-205, 1991
5. Kamper AL, Nielsen OJ: Effect of enalapril in haemoglobin and serum erythropoietin in patients with chronic nephropathy. Scand J Clin Lab Invest 50:611-618, 1990
6. Yoshida A, Morozumi K, Suganuma T, Aoki J, Sugito K, Nakamura S, Ikeda M, Oikawa T, Fujinami T, Kawahara H: Angiotensin-converting enzyme inhibitor and anemia in a patient undergoing hemodialysis. Nephron 59:334-335, 1991
7. Perazella M, McPhedran P, Kliger A, Lorber M, Levy E, Bia MJ: Enalapril treatment of posttransplant erythrocytosis: Efficacy independent of circulating erythropoietin levels. Am J Kidney Dis 26:495-500, 1995
8. Islam MS, Bourbigot B, Codet JP, Songy B, Fournier G, Cledes J: Captopril induces correction of postrenal transplant erythremia. Transplant Int 3:222-225, 1990
9. Gaston RS, Julian BA, Barker CV, Diethelm AG, Curtis JJ: Enalapril: Safe and effective therapy for posttransplant erythrocytosis. Transplant Proc 25:1029-1031, 1993
10. Rell K, Koziak K, Jarzyo I, Lao M, Gaciong Z: Correction of posttransplant erythrocytosis with enalapril. Transplantation 57:1059-1063, 1994
11. Gould AB, Goodman S, DeWolf R, Onesti G, Schwartz C: Interrelation of the renin system and erythropoietin in rats. J Lab Clin Med 96:523-534, 1980
12. Conlon PJ, Farrell J, Donohoe J, Carmody M, Walshe JJ: The beneficial effect of enalapril on erythrocytosis after renal transplantation. Transplantation 56:217-219, 1993
13. Rostaing L, Demur C, Huyn A, Durand D, Lloveras JJ, Sue JM: Erythrocytosis after renal transplant: Study of erythroid progenitors and response to enalapril. Transplant Proc 26:280-281, 1994
14. Walter J: Does captopril decrease the effect of human recombinant erythropoietin in haemodialysis patients? Nephrol Dial Transplant 8:1428, 1993 (letter)
15. Conlon PJ, Albers F, Butterly D, Schwab SJ: ACE inhibitors do not affect erythropoietin efficacy in haemodialysis patients. Nephrol Dial Transplant 9:1358, 1994 (letter)
16. Sanchez JA: ACE inhibitors do not decrease rHuEPO response in patients with end-stage renal failure. Nephrol Dial Transplant 10:1476, 1995 (letter)